Bridgeport Pathology Conslnts is categorized under Doctors in Bridgeport, CT .
Bridgeport Pathology Conslnts was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 5416183 by the NAICS.
If you are seeking more information, feel free to contact Michael L D'aiuto at the company’s single location by writing to 50 Ridgefield Avenue, Bridgeport, Connecticut CT 06610 or by phoning (203) 384-3631. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bridgeport Pathology Conslnts |
| Contact Person: | Michael L D'aiuto |
| Address: | 50 Ridgefield Avenue, Bridgeport, Connecticut 06610 |
| Phone Number: | (203) 384-3631 |
| Website Address: | bridgeporthospital.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 5416183 |
| Share This Business: |
Bridgeport Pathology Conslnts was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 5416183. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michael L D'aiuto for inquiries that concern Bridgeport Pathology Conslnts by calling the company number (203) 384-3631, as your correspondence is most welcome. Additionally, the physical location of the single location of Bridgeport Pathology Conslnts can be found at the coordinates 41.187486,-73.164202 as well as the street address 50 Ridgefield Avenue in Bridgeport, Connecticut 06610.
For its online presence, you may visit Bridgeport Pathology Conslnts’s website at bridgeporthospital.com and engage with its social media outlets through on Twitter and on Facebook.